Skip to main content
8X Ventures

Portfolio

D-NOME

Deviceless, room-temperature molecular diagnostics for affordable point-of-care testing.

D-NOME logo.

Sector

BioTech

Fund

SPV Portfolio

Invested at

Seed Stage

Status

Scaling from product validation to commercial deployment.

Molecular testing, without the machine.

D-NOME is a Hyderabad-based synthetic biology and molecular diagnostics company developing deviceless, room-temperature nucleic-acid amplification technology. Its proprietary D-LAMP platform is designed to make molecular testing simpler, faster and more affordable than conventional PCR.

Its technology platform is relevant to healthcare access because molecular tests such as RT-PCR are accurate but usually depend on costly instruments and trained personnel, limiting their use outside well-equipped laboratories. D-NOME is developing a one-reagent, one-step approach that removes the need for thermal-cycler hardware, for applications such as infectious-disease detection, antimicrobial-resistance screening and genome-sequencing workflows.

Alongside its diagnostic reagents, D-NOME offers a genome-sequencing reagent that compresses a multi-step protocol into a simpler workflow, and is developing D-ISO NAAT, a point-of-care molecular platform for TB screening at primary health centres. This mix of reagent products and point-of-care platform development positions the company to serve laboratories today and decentralised testing over time.

Why we invested

Accurate diagnosis cannot stay inside the laboratory.

Molecular tests such as RT-PCR are accurate, but they depend on costly instruments and trained personnel, which keeps them out of most clinics. A one-reagent, one-step test at room temperature changes where diagnosis can happen.

  • INFECTIOUS DISEASE
  • ANTIMICROBIAL RESISTANCE
  • TB SCREENING
  • GENOME SEQUENCING
  • PRIMARY HEALTH CENTRES

D-NOME is building for that world.

Company snapshot

Category

BioTech / Molecular Diagnostics

Founders

  • Divya Sriram Co-Founder & CEO
  • Sujoy Deb Co-Founder & CTO

Technology highlights

  • Room-temperature, deviceless D-LAMP nucleic-acid amplification
  • One-reagent, one-step molecular testing without RT-PCR machines
  • D-LAMP PCR enzyme mix and genome-sequencing reagent
  • D-ISO NAAT point-of-care platform for TB screening
  • Patent-pending reagent composition for diagnostics and genomics applications

8X View

Hard environments create hard companies.

We back founders building technology where the barrier is not just software speed, but engineering depth, technical resilience and real-world deployment.

D-NOME reflects that thesis.

Building deep technology for real markets?We would like to understandwhat you see before others do.

Back to Portfolio